Phase I evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virus
- 1 January 1993
- journal article
- clinical trial
- Published by Elsevier in The Journal of Pediatrics
- Vol. 122 (1), 137-144
- https://doi.org/10.1016/s0022-3476(05)83507-3
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Effect of continuous-infusion zidovudine therapy on neuropsychologic functioning in children with symptomatic human immunodeficiency virus infectionThe Journal of Pediatrics, 1990
- The Safety and Efficacy of Zidovudine (AZT) in the Treatment of Subjects with Mildly Symptomatic Human Immunodeficiency Virus Type 1 (HIV) InfectionAnnals of Internal Medicine, 1990
- Zidovudine in Asymptomatic Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1990
- Clinical Pharmacology of 3'-Azido-2',3'-Dideoxythymidine (Zidovudine) and Related DideoxynucleosidesNew England Journal of Medicine, 1989
- Azidothymidine Steady-State Pharmacokinetics in Patients with AIDS and AIDS-Related ComplexThe Journal of Infectious Diseases, 1989
- Effect of Continuous Intravenous Infusion of Zidovudine (AZT) in Children with Symptomatic HIV InfectionNew England Journal of Medicine, 1988
- A general model of metabolite kinetics following intravenous and oral administration of the parent drugBiopharmaceutics & Drug Disposition, 1988
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- Suppression of mouse viraemia and retroviral disease by 3′-azido-3′-deoxythymidineNature, 1986
- ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEXThe Lancet, 1986